GP-2250

· Geistlich Pharma AG

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GP-2250, covering 2025-09-11 to 2025-09-11. Get the full timeline:

Most recent: Clinical Trial Update: Trial to Evaluate Safety and Tolerability of GP-2250 in Combination With Gemcitabine [Phase 1]